2nd Annual Thought Leader Liaison Engagement Summit

JUNE 8-9, 2022 | Le Méridien in PHILADELPHIA, PA

AGENDA – ALL TIMES ARE IN EASTERN TIME

Saru Wade
Executive Director, Thought Leader Engagement Marketing
ALKERMES

Penny Sekerak 
Vice President, Clinical Affairs, Prof. ED, and Demand Generation 
NICO
This session will provide arguments both in favor and against having a standardized TLL role throughout the pharmaceutical industry. One TLL in favor and one TLL against with a Moderator that will allow the audience to provide questions and insight to the debating experts. The idea is for you to decide if you think it’s good as it is right now or if the TLL role should be uniform moving forward

  • Having the TLL role with different titles within the industry and with different duties and responsibilities
  • Being a new role within Pharma, the companies that are embracing TLLs are open to adding features and functions to make themselves more appealing, would this be of benefit for the TLL role in general
Facilitator:
Penny Sekerak 
Vice President, Clinical Affairs, Prof. ED, and Demand Generation 
NICO
  • What type of skills and soft skills are a Must have to be a great TLL
  • The right background! Is it Sales, Marketing, Medical?
  • Is it important to have a manager role before the TLL job?
Moderator:
Penny Sekerak 
Vice President, Clinical Affairs, Prof. ED, and Demand Generation 
NICO

Panelists:

Saru Wade
Executive Director, Thought Leader Engagement Marketing
ALKERMES

Susan Naboychik
Coagulation Thought Leader Liaison Director
ASTRAZENECA
In this session we will provide concrete steps you can take the same day to identify the true Digital Opinion Leaders in your therapeutic area.  Then we will look at how you can develop relationships with these experts to increase actionable insights and engage differently.

  • Know how to use the  3Rs DOL Identifier(TM) to find the true DOLs in your space
  • See a real life example of using AI to discover actionable insights
  • Walk away with 10 real-world examples of how to engage with DOLs
Scott Thompson
co-CEO
ACCELERATION POINT
A safe space to talk candidly through your challenges, new tools/tactics. Dedicated time, not only with the speakers but with your industry peers. This is an opportunity to have an engaged conversation with your industry counterparts and conference speakers.

We will divide the audience into small breakout groups (7 people per group) where we will engage in topics like “Digital Opinion Leaders” or the “The right qualities and features that make a great TLL” and they will talk about a specific topic for 15 minutes, then we will shift the audience to participate with another group of attendees in another topic discussion for 15 minutes.

Breakout Leader:

Scott Thompson
co-CEO
ACCELERATION POINT
  • Surround yourself with a capable team ready to lead internal communication into having a TLL buy-in everywhere in the company
  • The right amount of people for the team, the right preparation and the right skill set
  • Technological knowledge and space needed within the company to have a successful TLL department with different medical specialties
  • Have a clear understanding of the TLL responsibilities and duties inside the company
Saru Wade
Executive Director, Thought Leader Engagement Marketing
ALKERMES

Susan Naboychik
Coagulation Thought Leader Liaison Director
ASTRAZENECA
A safe space to talk candidly through your challenges, new tools/tactics. Dedicated time, not only with the speakers but with your industry peers. This is an opportunity to have an engaged conversation with your industry counterparts and conference speakers.

We will divide the audience into small breakout groups (7 people per group) where we will engage in topics like “Compliant internal stakeholder partnerships” or the “Building the TLL foundations” and they will talk about a specific topic for 15 minutes, then we will shift the audience to participate with another group of attendees in another topic discussion for 15 minutes.

Breakout Leader:

Badal Shah
Managing Director
QPHARMA
In this session we will provide proactive ways to engage and build long-lasting relationships to accelerate your success. Let’s explore:

  • The newer principles of purpose-driven communication
  • Practical ways to improve interprofessional collaboration
  • Innovative ways to improve engagement.
Priya Kartik
Founder and CEO
ENSPIRE ACADEMY
  • Balance an engaging and communicative relationship with your fellow MSLs to stay updated on what trends and ways to interact with KOLs
  • Delineate the TLL-MSL relationship to showcase a strong team and to ensure a complete experience for the KOLs working with your team
  • Compliant organization between Medical and Commercial
Jason Plant
Regional Sales Manager, Mid Atlantic
AURINIA PHARMACEUTICALS

Lauren DeRienzo
Associate Director, Global Medical Affairs
XENON PHARMACEUTICALS
Jason Plant
Regional Sales Manager, Mid Atlantic
AURINIA PHARMACEUTICALS

Wayne Winegarden
Senior Fellow and Director Center for Medical Economics and Innovation
PACIFIC RESEARCH INSTITUTE
Saru Wade
Executive Director, Thought Leader Engagement Marketing
ALKERMES Penny Sekerak 
Vice President, Clinical Affairs, Prof. ED, and Demand Generation 
NICO
  • The KOL leading the session will require the help of a volunteer from the audience to perform an exercise on how listening plays a key part in the KOL relationship
  • Learn best practices on how to become a great active listener
Owen Muir
KOL
PSYCHIATRY DOCTOR
  • Analyze the dynamism of the TLL role in different companies
  • Explore innovative ways to upskill and build a successful career
  • Adapt your TLL team to new and expanding roles
  • Hot growing role in the pharma industry, analyzing the reach and depth of a well performed TLL role
Jessica Outterson
Associate Director, Thought Leader Liaison
ALEXION PHARMACEUTICALS
  • Identify the thought leaders geographically, which are institutional and which are academia
  • Prioritize the engagement and interaction of the thought leaders that are most relevant for the stage in the product launch
  • Look for relevant opinion leaders in the communities and people that can be invested in an engaging successful interaction  
Penny Sekerak 
Vice President, Clinical Affairs, Prof. ED, and Demand Generation 
NICO
  • Learn insight on the OIG Fraud Alert and the effect on the KOL engagements
  • Enhance compliance initiatives to minimize risk in virtual KOL interactions
  • Understand the latest regulations and their effects on the interactions with KOLs moving forward
Deborah Penza
Group Chief Compliance Officer
HIKMA PHARMACEUTICALS

Bill Friedrich
Associate Director, Compliance
HIKMA PHARMACEUTICALS
A safe space to talk candidly through your challenges, new tools/tactics. Dedicated time, not only with the speakers but with your industry peers. This is an opportunity to have an engaged conversation with your industry counterparts and conference speakers.

We will divide the audience into small breakout groups (7 people per group) where we will engage in topics like “Standardizing the TLL role” or the “Evolution of the TLL role” and they will talk about a specific topic for 15 minutes, then we will shift the audience to participate with another group of attendees in another topic discussion for 15 minutes.
  • The use of technology on KOL evaluations, create your own internal criteria to evaluate
  • Type of criteria needed to tier KOLs accordingly
  • Virtual vs in-person – Paying what is right
Deborah Penza
Group Chief Compliance Officer
HIKMA PHARMACEUTICALS

Bill Friedrich
Associate Director, Compliance
HIKMA PHARMACEUTICALS
  • Engage with purpose, the ultimate goal of the KOL interaction is gathering insights that are key for the development of the product
  • Break the noise as you set yourself apart from the rest of TLLs, with one-on-one, dedicated engagement that will ensure your relationships with KOLs transcend
  • Provide innovative and purposeful encounters to generate a better synergy and to have a positive impact on every stakeholder throughout the product life cycle
Angie Simpson
Rare Blood TLL Field Development Manager
SANOFI
Renick Blosser
Director of Business Operations
ALKERMES